MLchartDataset catalogue

yttrium Y 90 monoclonal antibody BrE-3

Term · Oncology and biomedicine · MLC-T-ONC-017634

A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation.

Table 1. Record
IdentifierMLC-T-ONC-017634
FieldOncology and biomedicine
SynonymsMOAB BrE-3, yttrium Y 90
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017634",
  "term": "yttrium Y 90 monoclonal antibody BrE-3",
  "field": "Oncology and biomedicine",
  "definition": "A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation.",
  "synonyms": [
    "MOAB BrE-3, yttrium Y 90"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/yttrium-y-90-monoclonal-antibody-bre-3/"
}

Record 17,569 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.